Predicting breast cancer response to neoadjuvant therapy by integrating radiomic and deep-learning features from early-and-peak phases of DCE-MRI. Zhang Y, Cai J, Cui C, Qi S, et al. BMC Cancer 2025;25:1747.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Y, Cai J, Cui C, Qi S, et al. Predicting breast cancer response to neoadjuvant therapy by integrating radiomic and deep-learning features from early-and-peak phases of DCE-MRI. BMC Cancer 2025;25:1747.
PMID: 41219899